Valeant Pharmaceuticals North America, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. has received the United States Food and Drug Administration (FDA) approval for New Drug ...
There's a lot of toenail and fingernail fungus among us, enough that Topica Pharmaceuticals Inc., has raised $27 million in a Series B financing to support a Phase IIb/III trial of the privately held ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results